Clinical Trial Update: Go Fish: Omega-3 Fatty Acid Supplementation in Diabetes-Related Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating omega-3 fatty acid supplementation for diabetes-related kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Nephropathy

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Johns Hopkins University | Conditions: Diabetes | Phase 3 | Status: COMPLETED